Showing results 1 to 20 of 28
next >
| Issue Date | Title | Author(s) |
| Sep-2025 | Analysis of Cardiometabolic Multimorbidity Patterns and Influencing Factors Based on Association Rules | Xu, Jialiang; Liu, Xiaoqing; Chen, Mingjun; Dong, Yuting; Li, Linfeng; Wang, Peiyang; Chen, Shuyun; Wu, Shiming; Liu, Zhenghao; Wu, Siying; Guo, Jianhui |
| 2022 | CBLUE: A Chinese Biomedical Language Understanding Evaluation Benchmark | Zhang, Ningyu; Chen, Mosha; Bi, Zhen; Liang, Xiaozhuan; Li, Lei; Shang, Xin; Yin, Kangping; Tan, Chuanqi; Xu, Jian; Huang, Fei; Si, Luo; Ni, Yuan; Xie, Guotong; Sui, Zhifang; Chang, Baobao; Zong, Hui; Yuan, Zheng; Li, Linfeng; Yan, Jun; Zan, Hongying; Zhang, Kunli; Tang, Buzhou; Chen, Qingcai |
| 14-Aug-2023 | Characterization and application of a lactate and branched chain amino acid metabolism related gene signature in a prognosis risk model for multiple myeloma | Yu, Zhengyu; Qiu, Bingquan; Zhou, Hui; Li, Linfeng; Niu, Ting |
| 2018 | A comprehensive review of immune-mediated dermatopathology in systemic lupus erythematosus | Li, Qianwen; Wu, Haijing; Liao, Wei; Zhao, Ming; Chan, Vera; Li, Linfeng; Zheng, Min; Chen, Genhui; Zhang, Jianzhong; Lau, Chak-Sing; Lu, Qianjin |
| May-2023 | Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Asian patients with moderate to severe psoriasis: Findings from the phase 3 POETYK PSO-3 and PSO-4 trials | Foley, Peter; Zhang, Jianzhong; Imafuku, Shinichi; Ding, Yangfeng; Okubo, Yukari; Li, Hui; Tada, Yayoi; Li, Linfeng; Ohtsuki, Mamitaro; Pan, Weili; Lu, Yan; Hao, Cheng; Xian, Jiang; Ho, Ji-Chen; Guo, Shuping; Seo, Seong Jun; Napoli, Andrew; Chatterjee, Arkendu; Kisa, Renata M.; Banerjee, Subhashis; Morita, Akimichi |
| 17-Jul-2025 | Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Asian Patients With Moderate to Severe Psoriasis: Improvements in Patient-Reported Outcomes in a Randomized Trial | Zhang, Jianzhong; Ding, Yangfeng; Wang, Ping; Li, Linfeng; Pan, Weili; Lu, Yan; Cheng, Hao; Jiang, Xian; Ho, Ji-Chen; Guo, Shuping; Seo, Seong Jun; Gold, Linda Stein; Blauvelt, Andrew; Zhuo, Joe; Zhong, Yichen; Becker, Brandon; Liu, Leona; Banerjee, Subhashis; Thaci, Diamant |
| 21-Nov-2025 | Efficacy and Safety of Anti-IL-4Rα Stapokibart in Elderly Patients With Moderate-To-Severe Atopic Dermatitis | Zhao, Yan; Zhang, Litao; Wu, Liming; Yang, Bin; Wang, Jinyan; Li, Yumei; Diao, Qingchun; Li, Jingyi; Sun, Qing; Zhu, Xiaohong; Man, Xiaoyong; Wang, Lihua; Feng, Yanyan; Cai, Tao; Zeng, Huiming; Li, Linfeng; Lu, Jianyun; Ren, Hong; Li, Fuqiu; Lu, Qianjin; Tao, Xiaohua; Xiao, Rong; Ji, Chao; Sun, Jing; Qiu, Yanping; Chen, Bo; Zhang, Jianzhong |
| 2022 | EFFICACY AND SAFETY OF CM310 IN MODERATE-TO-SEVERE ATOPIC DERMATITIS: RESULTS FROM A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2B TRIAL IN CHINA | Zhang, Jianzhong; Yang, Bin; Li, Jingyi; Ding, Yangfeng; Wu, Liming; Zhang, Litao; Wang, Jinyan; Zhu, Xiaohong; Zhang, Furen; Tao, Xiaohua; Li, Yumei; Zhang, Chunlei; Li, Linfeng; Lu, Jianyun; Diao, Qingchun; Lu, Qianjin; Man, Xiaoyong; Li, Fuqiu; Xia, Xiujuan; Cheng, Hao; Zhao, Yan; Chen, Bo; Yan, Jinchun; Zhao, Guoqing; Jia, Yingmin |
| 2021 | EFFICACY AND SAFETY OF DUPILUMAB IN THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS IN CHINESE ADULTS: A MULTICENTER, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 TRIAL | Zhao, Yan; Wu, Liming; Lu, Qianjin; Gao, Xinghua; Zhu, Xiaohong; Yao, Xu; Li, Linfeng; Li, Wei; Ding, Yangfeng; Song, Zhiqiang; Liu, Lingling; Dang, Ningning; Zhang, Chunlei; Liu, Xiaoming; Gu, Jun; Wang, Jinyan; Geng, Songhai; Liu, Qunazhong; Guo, Yifeng; Lv, Dong; Ren, Gong; Yang, Xiumin; Deng, Danqi; Li, Shanshan; Han, Xiuping; Biao, Shuzhen; Zheng, Min; Dong, Li; Su, Huijuan; Bai, Lili; O'Malley, John T.; Luo, Junxiang; Zhang, Jianzhong |
| Nov-2025 | Efficacy and Safety of Stapokibart in Adults With Moderate-to-Severe Atopic Dermatitis With and Without Type 2 Comorbidities: A Post Hoc Analysis of a Phase 3 Trial | Zhao, Yan; Zhang, Litao; Wu, Liming; Yang, Bin; Wang, Jinyan; Li, Yumei; Diao, Qingchun; Li, Jingyi; Sun, Qing; Zhu, Xiaohong; Man, Xiaoyong; Wang, Lihua; Feng, Yanyan; Cai, Tao; Zeng, Huiming; Li, Linfeng; Lu, Jianyun; Ren, Hong; Li, Fuqiu; Lu, Qianjin; Tao, Xiaohua; Xiao, Rong; Ji, Chao; Zhao, Wenjie; Chu, Wei; Chen, Bo; Zhang, Jianzhong |
| Aug-2022 | An Efficient Method for Deidentifying Protected Health Information in Chinese Electronic Health Records: Algorithm Development and Validation | Wang, Peng; Li, Yong; Yang, Liang; Li, Simin; Li, Linfeng; Zhao, Zehan; Long, Shaopei; Wang, Fei; Wang, Hongqian; Li, Ying; Wang, Chengliang |
| 30-Aug-2022 | An emerging prognosis prediction model for multiple myeloma: Hypoxia-immune related microenvironmental gene signature | Yu, Zhengyu; Qiu, Bingquan; Li, Linfeng; Xu, Jing; Zhou, Hui; Niu, Ting |
| 2013 | Identification of the critical amino acid residues of immunoglobulin E and immunoglobulin G epitopes on alpha(s1)-casein by alanine scanning analysis | Cong, Yanjun; Yi, Hong; Qing, Yuting; Li, Linfeng |
| 2024 | In-Situ Polymer Framework Strategy Enabling Printable and Efficient Perovskite Solar Cells by Mitigating "Coffee Ring" Effect | Li, Linfeng; Huang, Zengqi; Meng, Xiangchuan; Xing, Zhi; Fan, Baojin; Li, Jiaxuan; Chen, Yiwang |
| 2021 | LABORATORY SAFETY OF DUPILUMAB AND ITS EFFECT ON INFLAMMATORY BIOMARKERS IN ADULT CHINESE PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: AN ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND PHASE III STUDY | Zhao, Yan; Wu, Liming; Lu, Qianjin; Gao, Xinghua; Zhu, Xiaohong; Yao, Xu; Li, Linfeng; Li, Wei; Ding, Yangfeng; Song, Zhiqiang; Liu, Lingling; Dang, Ningning; Zhang, Chunlei; Liu, Xiaoming; Gu, Jun; Wang, Jinyan; Geng, Songmei; Liu, Quanzhong; Guo, Yifeng; Lv, Dong; Ren, Hong; Yang, Xiumin; Deng, Danqi; Li, Shanshan; Han, Xiuping; Biao, Zhenshu; Zheng, Min; Dong, Lichee; Su, Huijuan; Bai, Lili; O'Malley, John T.; Luo, Junxiang; Li, Yi; Wang, Min; Fan, Xinli; Zhang, Jianzhong |
| 25-Oct-2024 | Long-term efficacy and safety of stapokibart for moderate-to-severe atopic dermatitis: 52-week results from a phase 3 trial | Zhao, Yan; Zhang, Litao; Wu, Liming; Yang, Bin; Wang, Jinyan; Li, Yumei; Li, Jingyi; Diao, Qingchun; Sun, Qing; Zhu, Xiaohong; Man, Xiaoyong; Wang, Lihua; Li, Linfeng; Feng, Yanyan; Zeng, Huiming; Cai, Tao; Ren, Hong; Lu, Jianyun; Lu, Qianjin; Tao, Xiaohua; Xiao, Rong; Ji, Chao; Li, Fuqiu; Zhang, Jianzhong |
| 30-Mar-2020 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Compound Glycyrrhizin Capsules Combined with a Topical Corticosteroid in Adults with Chronic Eczema | Xu, Wei; Li, Yan; Ju, Mei; Lai, Wei; Lu, Xueyan; Shi, Huijuan; Shi, Weimin; Gu, Heng; Li, Linfeng |
| Jan-2026 | Novel TYK2 inhibitor D-2570 in moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled, phase 2 trial | Zhang, Jianzhong; Zhou, Cheng; Miao, Guoying; Zhang, Shoumin; Duan, Xinsuo; Wu, Liming; Zhang, Guoqiang; Dang, Ningning; Ding, Yangfeng; Han, Hongfang; Wei, Aihua; Yang, Bin; Li, Linfeng; Li, Shanshan; Dai, Xunyi; Zhang, Jianglin; Lei, Tiechi; Yan, Wenjie; Zhang, Lixia; Meng, Zudong; Chen, Rixin; Song, Qiuhe; Wang, Liangchun; Wang, Wenhui; Hu, Xinglin; Xiang, Ziyong; Shi, Zhe; Zhang, Ling |
| 12-Jul-2025 | Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis Treated with Stapokibart over 52 weeks: A Post Hoc Analysis of a Phase 3 Trial | Zhao, Yan; Zhang, Litao; Wu, Liming; Yang, Bin; Wang, Jinyan; Li, Yumei; Diao, Qingchun; Li, Jingyi; Sun, Qing; Zhu, Xiaohong; Man, Xiaoyong; Wang, Lihua; Feng, Yanyan; Cai, Tao; Zeng, Huiming; Li, Linfeng; Lu, Jianyun; Ren, Hong; Li, Fuqiu; Lu, Qianjin; Tao, Xiaohua; Xiao, Rong; Ji, Chao; Liang, Chao; Qiu, Yanping; Chen, Bo; Zhang, Jianzhong |
| 7-Aug-2024 | Polymer modulated ink rheology and compatibility enables homogenized printing of a Spiro-OMeTAD transport layer for scalable and stable perovskite solar modules | Li, Jin; Fan, Baojing; Liu, Xukai; Liu, Yuxin; Xing, Zhi; Gong, Chenxiang; Chu, Zhaoyang; Li, Linfeng; Meng, Xiangchuan; Guo, Rui; Wang, Fuyi; Hu, Xiaotian; Chen, Yiwang |
